Exelixis
EXEL
#1647
Rank
$13.32 B
Marketcap
$53.03
Share price
-5.25%
Change (1 day)
42.32%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company